Skip to main content
Feature Story

Programmable sensitivity

By Stephen Parmley, Senior Writer

Programmable sensitivity

Since the GAIN Act was passed in 2012 to stimulate new antibiotic development, there has been more interest in the field but no game changers have emerged, and antibiotic resistance is still a major problem. Two independent teams believe they could have a far-reaching solution in the gene editing technology CRISPR, which allows them to tailor therapies to specific resistance mutations.1,2

Full Article

Today's Biotech & Pharma News

Chilling Reality

Subscribe Now
Free Trial